ILA ASX · Health Care

Island Pharmaceuticals Ltd

Announcements, last 12 months: 81
Price sensitive, last 12 months: 39
Followed on InvestorPA: Some (Among the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
23 Oct 2026, 9:22 AM	Letter to Shareholders, Notice of AGM & Proxy Form
19 Oct 2026, 9:31 AM	USAMRIID Marburg study advances towards dosing Price sensitive	AI summary
9 Oct 2026, 2:07 PM	Notification regarding unquoted securities - ILA
2 Oct 2026, 9:41 AM	Galidesivir GMP manufacturing commences Price sensitive	AI summary
30 Sep 2026, 11:53 AM	Annual General Meeting - Rescheduled Date
31 Aug 2026, 9:01 AM	Pivotal Marburg data secured for Galidesivir FDA pathway Price sensitive	AI summary
26 Aug 2026, 3:16 PM	Appendix 4G and Corporate Governance Statement
26 Aug 2026, 3:16 PM	Annual Report to shareholders
26 Aug 2026, 3:04 PM	Preliminary Final Report Price sensitive	AI summary
21 Aug 2026, 8:56 AM	Island boosts Galidesivir supply as Ebola surges Price sensitive	AI summary

Sign in to see all ILA announcements.

Guidance history

26 Aug 2026	Income from ordinary activities: $559,080; Loss after tax: $(9,843,987) for the year ended 30 June 2026
21 Aug 2026	Expected to have 700-800 treatment courses of Galidesivir by Q4 CY26
7 Jul 2026	No specific financial guidance provided in the announcement

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow ILA to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.